Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.1T | 2.9T | 3.2T | 2.7T |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 319.8B | 393.2B | 326.5B | 330.5B |
| Other operating expenses | 96.8B | 100.0B | 108.0B | 87.5B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.0T | 1.0T | 1.6T | 936.7B |
| Tax provision | 230.1B | 227.5B | 361.4B | 214.4B |
| Net income | 789.0B | 780.9B | 1.3T | 722.3B |
| Basic EPS | 22 | — | — | — |
| Diluted EPS | 22 | — | — | — |
| Basic average shares | 36.2B | — | — | — |
| Diluted average shares | 36.2B | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |